XE
Director, Pharmacometrics & Quantitative Medicine
Lead the pre-clinical and clinical investigation of PKPD, safety, and efficacy relationships for novel T-cell engagers and immune-based therapeutics. Build population models to inform dose selection, support regulatory interactions, and collaborate cross-functionally to optimize dose-escalation and RP2D decisions.